A Joint Statement from the American Thyroid Association, the European Association of Nuclear Medicine, the European Thyroid Association, the Society of Nuclear Medicine and Molecular Imaging on Current Diagnostic and Theranostic Approaches in the Management of Thyroid Cancer
Authors:
- Seza A. GulecSGSeza A. Gulec
- Sukhjeet AhujaSASukhjeet Ahuja
- Anca M. AvramAAAnca M. Avram
- Victor J. BernetVBVictor J. Bernet
- Patrick BourguetPBPatrick Bourguet
- Ciprian DraganescuCDCiprian Draganescu
- Rossella EliseiRERossella Elisei
- Luca GiovanellaLGLuca Giovanella
- Frederick D GrantFGFrederick D Grant
- Bennett GreenspanBGBennett Greenspan
- Laszlo HegedüsLHLaszlo Hegedüs
- Jacqueline JonklaasJJJacqueline Jonklaas
- 8 July 2021
- journal article
- research article
- Published by SAGE Publications in Thyroid®
- Vol. 31 (7) , 1009-1019
Abstract
Background: The American Thyroid Association (ATA), the European Association of Nuclear Medicine, the European Thyroid Association, and the Society of Nuclear Medicine and Molecular Imaging have established an intersocietal working group to address the current controversies and evolving concepts in thyroid cancer management and therapy. The working group annually identifies topics that may significantly impact clinical practice and publishes expert opinion articles reflecting intersocietal collaboration, consensus, and suggestions for further research to address these important management issues. Summary: In 2019, the intersocietal working group identified the following topics for review and interdisciplinary discussion: (i) perioperative risk stratification, (ii) the role of diagnostic radioactive iodine (RAI) imaging in initial staging, and (iii) indicators of response to RAI therapy. Conclusions: The intersocietal working group agreed that (i) initial patient management decisions should be guided by perioperative risk stratification that should include the eighth edition American Joint Committee on Cancer staging system to predict disease specific mortality, the modified 2009 ATA risk stratification system to estimate structural disease recurrence, with judicious incorporation of molecular theranostics to further refine management recommendations; (ii) diagnostic RAI scanning in ATA intermediate risk patients should be utilized selectively rather than being considered mandatory or not necessary for all patients in this category; and (iii) a consistent semiquantitative reporting system should be used for response evaluations after RAI therapy until a reproducible and clinically practical quantitative system is validated.Keywords
This publication has 57 references indexed in Scilit:
- Brief progress report from the intersocietal working group on differentiated thyroid cancerEuropean Journal of Nuclear Medicine and Molecular Imaging, 2020
- The Martinique PrinciplesJournal of Nuclear Medicine, 2019
- Controversies, Consensus, and Collaboration in the Use of 131 I Therapy in Differentiated Thyroid Cancer: A Joint Statement from the American Thyroid Association, the European Association of Nuclear Medicine, the Society of Nuclear Medicine and Molecular Imaging, and the European Thyroid AssociationThyroid®, 2019
- Risk Stratification in Differentiated Thyroid Cancer: From Detection to Final Follow-UpThe Journal of Clinical Endocrinology & Metabolism, 2019
- Updated American Joint Committee on Cancer/Tumor-Node-Metastasis Staging System for Differentiated and Anaplastic Thyroid Cancer (Eighth Edition): What Changed and Why?Thyroid®, 2017
- Exploring the Relationship Between Patient Age and Cancer-Specific Survival in Papillary Thyroid Cancer: Rethinking Current Staging SystemsJournal of Clinical Oncology, 2016
- 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid CancerThyroid®, 2016
- Survival from Differentiated Thyroid Cancer: What Has Age Got to Do with It?Thyroid®, 2015
- American Thyroid Association Statement on the Essential Elements of Interdisciplinary Communication of Perioperative Information for Patients Undergoing Thyroid Cancer SurgeryThyroid®, 2012
- Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid CancerThyroid®, 2009